69,291 Shares in Veeva Systems Inc. $VEEV Acquired by Nykredit A S

Nykredit A S purchased a new stake in Veeva Systems Inc. (NYSE:VEEV) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 69,291 shares of the technology company’s stock, valued at approximately $12,297,000.

Other hedge funds also recently added to or reduced their stakes in the company. SHP Wealth Management acquired a new stake in Veeva Systems during the fourth quarter worth approximately $26,000. Arlington Trust Co LLC acquired a new position in shares of Veeva Systems in the 2nd quarter valued at $29,000. Field & Main Bank purchased a new position in shares of Veeva Systems in the 2nd quarter valued at $29,000. MV Capital Management Inc. acquired a new stake in Veeva Systems during the 4th quarter worth $30,000. Finally, Reflection Asset Management acquired a new stake in Veeva Systems during the 4th quarter worth $32,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on VEEV shares. Stifel Nicolaus set a $300.00 price objective on shares of Veeva Systems in a research note on Thursday, August 27th. Citigroup boosted their target price on Veeva Systems from $190.00 to $273.00 and gave the company a “neutral” rating in a report on Friday, August 28th. Robert W. Baird upped their target price on Veeva Systems from $260.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Raymond James Financial restated an “outperform” rating and set a $225.00 price target on shares of Veeva Systems in a research note on Thursday, June 4th. Finally, BNP Paribas Exane reiterated an “outperform” rating and issued a $285.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. Nineteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $284.46.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

Veeva Systems Stock Down 3.6%

Shares of VEEV stock opened at $274.02 on Friday. The stock’s 50-day moving average price is $220.49 and its 200 day moving average price is $187.95. The stock has a market capitalization of $44.51 billion, a PE ratio of 45.07, a price-to-earnings-growth ratio of 1.21 and a beta of 0.97. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The company had revenue of $927.96 million during the quarter, compared to analysts’ expectations of $905.38 million. During the same period last year, the firm earned $1.99 EPS. The firm’s revenue for the quarter was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Analysts expect that Veeva Systems Inc. will post 6.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Thomas Schwenger sold 36,000 shares of Veeva Systems stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at $4,866,723.27. This trade represents a 64.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.